HC VIOLET NO. 2 | CAS:104226-19-9

We serve HC VIOLET NO. 2 CAS:104226-19-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
HC VIOLET NO. 2

Chemical Name:HC VIOLET NO. 2
CAS.NO:104226-19-9
Synonyms: HC Violet 2
Molecular Formula:C13H21N3O5
Molecular Weight:299.323
 
Specification:
Appearance:Dark brown powder
Purity(HPLC):≥99.0%
Ash:≤0.5%
Loss on drying:≤0.5%
Fe content:≤100ppm
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Hair dyes intermediate
 



Contact us for information like HC VIOLET NO. 2 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,HC Violet 2 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,HC VIOLET NO. 2 Use and application,HC VIOLET NO. 2 technical grade,usp/ep/jp grade.


Related News: What is the difference? Raw material refers to chemical compounds that are used as a base to make an API.1-Aminoindane Hydrochloride manufacturer What is the difference? Raw material refers to chemical compounds that are used as a base to make an API.3-Mercaptopropyltriethoxysilane supplier Any South Korean citizen returning home who has been in Hubei Province within the past two weeks will be subject to 14 days of self-quarantine and monitoring, the government said.1-(7-broMo-9,9-difluoro-9H-fluoren-2-yl)-2-chloro-Ethanone vendor At present, Teva can produce more than 300 generic drugs, and the API department has approximately 650 authorized patents and patent applications worldwide. It is also the generic drug company with the most challenges in patenting ParagraphIV in the world.At present, Teva can produce more than 300 generic drugs, and the API department has approximately 650 authorized patents and patent applications worldwide. It is also the generic drug company with the most challenges in patenting ParagraphIV in the world.